Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy

Objective: Autologous hematopoietic stem cell transplantation (AHSCT) is a therapeutic option for patients with severe and progressive systemic sclerosis (SSc). Here, we aimed to investigate how AHSCT affects the vasculopathy of SSc patients. Methods: Twenty-seven SSc patients were retrospectively a...

Full description

Bibliographic Details
Main Authors: Maynara Santana-Gonçalves, Djúlio Zanin-Silva, Álvaro Henrique-Neto, Daniela A. Moraes, Marianna Y. Kawashima- Vasconcelos, João R. Lima-Júnior, Juliana B. E. Dias, Vinícius Bragagnollo, Júlia T. C. de Azevedo, Dimas T. Covas, Kelen C. R. Malmegrim, Leandra Ramalho, Maria Carolina Oliveira
Format: Article
Language:English
Published: SAGE Publishing 2022-03-01
Series:Therapeutic Advances in Musculoskeletal Disease
Online Access:https://doi.org/10.1177/1759720X221084845